[144] Astera Labs, Inc. SEC Filing
Astera Labs' Form 144 discloses a proposed sale of 26,000 common shares on NASDAQ through broker Stifel, with an aggregate market value of $4,556,737.00 and the issuer reported 162,150,000 shares outstanding. The filing shows the shares were acquired in private placements: 1,000 on 05/17/2022 and 25,000 on 11/08/2019. A related sale by Stefan A Dyckerhoff of 26,000 shares on 08/07/2025 for $4,508,959.00 is also listed. The notice includes the seller's representation that they do not possess undisclosed material adverse information and contains the standard legal warning about intentional misstatements.
Il Form 144 di Astera Labs segnala una proposta di vendita di 26,000 azioni ordinarie su NASDAQ tramite il broker Stifel, con un valore di mercato complessivo di $4,556,737.00 e l'emittente ha riportato 162,150,000 azioni in circolazione. La documentazione indica che le azioni sono state acquisite in collocamenti privati: 1,000 il 05/17/2022 e 25,000 il 11/08/2019. 脠 inoltre elencata una vendita correlata da parte di Stefan A Dyckerhoff di 26,000 azioni il 08/07/2025 per $4,508,959.00. L'avviso include la dichiarazione del venditore di non essere in possesso di informazioni negative materiali non divulgate e contiene l'avvertimento legale standard riguardo a dichiarazioni intenzionalmente false.
El Form 144 de Astera Labs revela una propuesta de venta de 26,000 acciones ordinarias en NASDAQ a trav茅s del corredor Stifel, con un valor de mercado agregado de $4,556,737.00 y el emisor inform贸 162,150,000 acciones en circulaci贸n. La presentaci贸n muestra que las acciones se adquirieron en colocaciones privadas: 1,000 el 05/17/2022 y 25,000 el 11/08/2019. Tambi茅n figura una venta relacionada por parte de Stefan A Dyckerhoff de 26,000 acciones el 08/07/2025 por $4,508,959.00. El aviso incluye la declaraci贸n del vendedor de que no posee informaci贸n adversa material no divulgada y contiene la advertencia legal est谩ndar sobre declaraciones intencionalmente falsas.
Astera Labs鞚� Form 144電� 欷戧皽鞚� Stifel鞚� 韱淀暣 NASDAQ鞐愳劀 26,000 氤错喌欤� 毵り皝鞚� 鞝滌晥頄堨潓鞚� 瓿店皽頃橂┌, 齑� 鞁滉皜齑濎暋鞚� $4,556,737.00鞚搓碃 氚滍枆靷姅 162,150,000欤茧ゼ 氚滍枆欤检嫕靾橂 鞁犼碃頄堨姷雼堧嫟. 鞁犾箔靹滌棎電� 頃措嫻 欤检嫕鞚� 靷 氚滍枆鞙茧 旆摑霅橃棃鞚岇潉 雮橅儉雮措┌, 攴� 雮挫棴鞚� 05/17/2022鞐� 1,000欤�, 11/08/2019鞐� 25,000欤检瀰雼堧嫟. 霕愴暅 Stefan A Dyckerhoff鞚� 08/07/2025鞛� 26,000欤� 毵り皝(旮堨暋: $4,508,959.00)霃� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 韱奠氍胳棎電� 韺愲Г鞛愱皜 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 氤挫湢頃橁碃 鞛堨 鞎婋嫟電� 歆勳垹瓿� 瓿犾潣鞝� 項堨渼歆勳垹鞐� 雽�頃� 響滌 氩曥爜 瓴疥碃臧� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Le Form 144 d'Astera Labs r茅v猫le une cession envisag茅e de 26,000 actions ordinaires sur le NASDAQ via le courtier Stifel, pour une valeur de march茅 totale de $4,556,737.00, et l'茅metteur a d茅clar茅 162,150,000 actions en circulation. Le dossier indique que les actions ont 茅t茅 acquises lors de placements priv茅s : 1,000 le 05/17/2022 et 25,000 le 11/08/2019. Une cession li茅e par Stefan A Dyckerhoff de 26,000 actions le 08/07/2025 pour $4,508,959.00 est 茅galement mentionn茅e. L'avis inclut la d茅claration du vendeur selon laquelle il ne d茅tient pas d'informations d茅favorables mat茅rielles non divulgu茅es et contient l'avertissement juridique standard concernant les fausses d茅clarations intentionnelles.
Das Form 144 von Astera Labs legt einen geplanten Verkauf von 26,000 Stammaktien an der NASDAQ 眉ber den Broker Stifel offen, mit einem aggregierten Marktwert von $4,556,737.00. Der Emittent meldete 162,150,000 ausstehende Aktien. Die Einreichung weist aus, dass die Aktien in Privatplatzierungen erworben wurden: 1,000 am 05/17/2022 und 25,000 am 11/08/2019. Ebenfalls aufgef眉hrt ist ein damit zusammenh盲ngender Verkauf durch Stefan A Dyckerhoff von 26,000 Aktien am 08/07/2025 蹿眉谤 $4,508,959.00. Die Mitteilung enth盲lt die Darstellung des Verk盲ufers, dass er nicht im Besitz nicht offengelegter wesentlicher nachteiliger Informationen ist, sowie die 眉bliche rechtliche Warnung vor vors盲tzlichen Falschangaben.
- None.
- None.
Insights
TL;DR: Form 144 discloses a proposed sale of 26,000 ALAB common shares via Stifel on NASDAQ.
The filing specifies the intended transaction size (26,000 shares) and the stated aggregate market value ($4,556,737.00), plus the company's outstanding share count (162,150,000). It also documents prior acquisitions by the filer through private placements and a recent sale by Stefan A Dyckerhoff on 08/07/2025. The form contains the seller's certification regarding material nonpublic information, consistent with normal Rule 144 disclosures.
TL;DR: Filing includes required seller representations and a transaction record; it documents acquisition dates and a recent sale.
The notice includes explicit acquisition history (private placements on 11/08/2019 and 05/17/2022), the broker on record (Stifel), and the seller's declaration about undisclosed material information. Those elements align with Rule 144 procedural disclosure requirements and provide a clear audit trail for the reported transactions.
Il Form 144 di Astera Labs segnala una proposta di vendita di 26,000 azioni ordinarie su NASDAQ tramite il broker Stifel, con un valore di mercato complessivo di $4,556,737.00 e l'emittente ha riportato 162,150,000 azioni in circolazione. La documentazione indica che le azioni sono state acquisite in collocamenti privati: 1,000 il 05/17/2022 e 25,000 il 11/08/2019. 脠 inoltre elencata una vendita correlata da parte di Stefan A Dyckerhoff di 26,000 azioni il 08/07/2025 per $4,508,959.00. L'avviso include la dichiarazione del venditore di non essere in possesso di informazioni negative materiali non divulgate e contiene l'avvertimento legale standard riguardo a dichiarazioni intenzionalmente false.
El Form 144 de Astera Labs revela una propuesta de venta de 26,000 acciones ordinarias en NASDAQ a trav茅s del corredor Stifel, con un valor de mercado agregado de $4,556,737.00 y el emisor inform贸 162,150,000 acciones en circulaci贸n. La presentaci贸n muestra que las acciones se adquirieron en colocaciones privadas: 1,000 el 05/17/2022 y 25,000 el 11/08/2019. Tambi茅n figura una venta relacionada por parte de Stefan A Dyckerhoff de 26,000 acciones el 08/07/2025 por $4,508,959.00. El aviso incluye la declaraci贸n del vendedor de que no posee informaci贸n adversa material no divulgada y contiene la advertencia legal est谩ndar sobre declaraciones intencionalmente falsas.
Astera Labs鞚� Form 144電� 欷戧皽鞚� Stifel鞚� 韱淀暣 NASDAQ鞐愳劀 26,000 氤错喌欤� 毵り皝鞚� 鞝滌晥頄堨潓鞚� 瓿店皽頃橂┌, 齑� 鞁滉皜齑濎暋鞚� $4,556,737.00鞚搓碃 氚滍枆靷姅 162,150,000欤茧ゼ 氚滍枆欤检嫕靾橂 鞁犼碃頄堨姷雼堧嫟. 鞁犾箔靹滌棎電� 頃措嫻 欤检嫕鞚� 靷 氚滍枆鞙茧 旆摑霅橃棃鞚岇潉 雮橅儉雮措┌, 攴� 雮挫棴鞚� 05/17/2022鞐� 1,000欤�, 11/08/2019鞐� 25,000欤检瀰雼堧嫟. 霕愴暅 Stefan A Dyckerhoff鞚� 08/07/2025鞛� 26,000欤� 毵り皝(旮堨暋: $4,508,959.00)霃� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 韱奠氍胳棎電� 韺愲Г鞛愱皜 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 氤挫湢頃橁碃 鞛堨 鞎婋嫟電� 歆勳垹瓿� 瓿犾潣鞝� 項堨渼歆勳垹鞐� 雽�頃� 響滌 氩曥爜 瓴疥碃臧� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Le Form 144 d'Astera Labs r茅v猫le une cession envisag茅e de 26,000 actions ordinaires sur le NASDAQ via le courtier Stifel, pour une valeur de march茅 totale de $4,556,737.00, et l'茅metteur a d茅clar茅 162,150,000 actions en circulation. Le dossier indique que les actions ont 茅t茅 acquises lors de placements priv茅s : 1,000 le 05/17/2022 et 25,000 le 11/08/2019. Une cession li茅e par Stefan A Dyckerhoff de 26,000 actions le 08/07/2025 pour $4,508,959.00 est 茅galement mentionn茅e. L'avis inclut la d茅claration du vendeur selon laquelle il ne d茅tient pas d'informations d茅favorables mat茅rielles non divulgu茅es et contient l'avertissement juridique standard concernant les fausses d茅clarations intentionnelles.
Das Form 144 von Astera Labs legt einen geplanten Verkauf von 26,000 Stammaktien an der NASDAQ 眉ber den Broker Stifel offen, mit einem aggregierten Marktwert von $4,556,737.00. Der Emittent meldete 162,150,000 ausstehende Aktien. Die Einreichung weist aus, dass die Aktien in Privatplatzierungen erworben wurden: 1,000 am 05/17/2022 und 25,000 am 11/08/2019. Ebenfalls aufgef眉hrt ist ein damit zusammenh盲ngender Verkauf durch Stefan A Dyckerhoff von 26,000 Aktien am 08/07/2025 蹿眉谤 $4,508,959.00. Die Mitteilung enth盲lt die Darstellung des Verk盲ufers, dass er nicht im Besitz nicht offengelegter wesentlicher nachteiliger Informationen ist, sowie die 眉bliche rechtliche Warnung vor vors盲tzlichen Falschangaben.
FAQ
What does the ALAB Form 144 disclose?
Who is the seller named in the Form 144?
When is the approximate sale date and which exchange is listed?
How were the shares being sold originally acquired?
How many shares does the issuer report outstanding?
